Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Sutab expiration issues?Allergan restasis sales 2004?Dalfampridine generic name?Certolizumab pegol patent expiry us?According to recent market data tezspire tezepelumab had a 7 1 share of paid biologic prescriptions trx in the u's from may 2023 to april 2024?
See the DrugPatentWatch profile for ruxolitinib
Apotex’s ruxolitinib gained US approval on July 12, 2011.[1]
This approval refers to an Apotex ruxolitinib product made available in the United States under the brand name Jakafi (ruxolitinib) approval history coverage in DrugPatentWatch’s database.[1]
[1] https://www.drugpatentwatch.com/patent/US-8377884/apotex-inc/
Other Questions About Ruxolitinib :